BackgroundCheck.run
Search For

Hui Li, 37Bellevue, WA

Known as:
Li Hui
Related to:
Mingshen M Sun Li Y Mo 63

Hui Li Phones & Addresses

Bellevue, WA   

647 Garland Ave, Sunnyvale, CA 94086   

Richardson, TX   

Lubbock, TX   

Willowbrook, IL   

Get Report
Control this profile

Mentions for Hui Li

Hui Li resumes & CV records

Resumes

Hui Li Photo 46

Hui Li - Kenmore, WA

Work:
Google - Singapore Jun 2014 to Sep 2014
MBA Marketing Intern EMC CORPORATION - Seattle, WA Jan 2014 to Mar 2014
MBA Consultant TAYLOR NELSEN SOFRES SINGAPORE PTE LTD - Singapore 2010 to 2013
Regional Market Research Analyst MARKET PROBE ASIA PACIFIC PTE LTD - Singapore 2009 to 2009
Market Research Assistant (Intern) WATSON WYATT CONSULTING 2007 to 2007
Project Assistant (Intern)
Education:
NATIONAL UNIVERSITY OF SINGAPORE - Singapore Jul 2010
MBA in Marketing Association FUDAN UNIVERSITY Jul 2008
Bachelor of Law in Sociology THE MICHAEL G. FOSTER SCHOOL OF BUSINESS, UNIVERSITY OF WASHINGTON - Seattle, WA
Master of Business Administration in Marketing/Marketing Research
Skills:
Google AdWords Certification Advanced Market Research Certificates & Professional Member of United Kingdom Market Research Society Languages: English (fluent oral and written); Chinese (native); Cantonese (intermediate) Proficient with data analysis tools: e.g. Excel, MS Access, SPSS, SQL
Hui Li Photo 47

Hui Li - St. Louis, MO

Work:
PSA Oct 2012 to Dec 2012
Consultant Intern INGERSOLL RAND (CHINA) INVESTMENT CO., LTD Jun 2012 to Sep 2012
Accounting Intern KPMG (SGP) Jan 2012 to Feb 2012
Audit Intern PINGAN BANK - Shenzhen, CN Aug 2011 to Sep 2011
Law and Compliance Department Intern
Education:
SHANGHAI INTERNATIONAL STUDIES UNIVERSITY Jul 2013
Bachelor of Art in English Language and Literature WASHINGTON UNIVERSITY, OLIN BUSINESS SCHOOL - St. Louis, MO
Master of Accounting
Skills:
Microsoft Office, Oracle Financial System
Hui Li Photo 48

Hui Li - Richardson, TX

Work:
Texas Tech University Sep 2009 to Dec 2013
Teaching Assistant, Chem
Education:
The University of Texas at Dallas - Richardson, TX 2014 to 2016
M.S. in Computer Science Texas Tech University - Lubbock, TX Aug 2009 to Aug 2014
PhD in Chemistry Huazhong University of Science & Technology - Wuhan, CN Sep 2005 to Jun 2009
B.S. in Applied Chemistry
Skills:
Proficient in Java, Python programming and Data analysis Familiar with R, Octave, SML, Unix and MIPS Assembly Prior Experience in C/C++, MySQL, Matlab, CSS, HTML, JavaScript, XML
Hui Li Photo 49

Hui Li

Work:
Post-doctoral Researcher Jan 2010 to 2000 Hui Li 2013 to 2013 Beijing Information Technology Center Embedded Engineering Group Jul 2009 to Jan 2010
project manager to develop a portable Primary developer 2008 to 2008 Beijing E-Dragons Intelligent Network Limited Company Jul 1997 to Jun 2002
a software Hui Li Jul 1994 to May 1997
Education:
College of Computer Science and Technology, Beijing University of Technology 2013
Ph. D. in Computer Application Technology Actuator of this University-Enterprise 2006
doctoral in research College of Computer Science and Technology - Changchun, CN Sep 2001 to Jul 2004
Master of Science in Computer Application Technology College of Computer Science and Technology, Jinlin University - Changchun, CN Sep 1990 to Jul 1994
B.S. in Computer Application Technology ShouGang Research Institute
cooperation
Hui Li Photo 50

Hui Li

Work:
Post-doctoral Researcher Jan 2010 to 2000 Hui Li 2013 to 2013 Beijing Information Technology Center Embedded Engineering Group Jul 2009 to Jan 2010
project manager to develop a portable Primary developer 2008 to 2008 Beijing E-Dragons Intelligent Network Limited Company Jul 1997 to Jun 2002 Changchun Sitong Electronic Communication Company Jul 1994 to May 1997
Education:
College of Computer Science and Technology, Beijing University of Technology Sep 2004 to Jun 2009
Ph. D. in Computer Application Technology Actuator of this University-Enterprise 2006
doctoral in research College of Computer Science and Technology - Changchun, CN Sep 2001 to Jul 2004
Master of Science in Computer Application Technology College of Computer Science and Technology, Jinlin University - Changchun, CN Sep 1990 to Jul 1994
B.S. in Computer Application Technology ShouGang Research Institute
cooperation
Hui Li Photo 51

Hui Li - Lenexa, KS

Work:
Applied Bioinformatics Laboratory May 2011 to 2000
Web Developper LAB EXPERIENCE
Education:
Illinois Institute of Technology - Chicago, IL Jan 2008 to Jan 2011
Master of Science in Electrical & Computer Engineering Hebei University of Science and Technology - Hebei.China Jan 2002 to Jan 2006
BS in Electrical Engineering
Skills:
Solaris, Linux, Windows [] OSPF, Telnet, EIGRP, VLAN, VTP, STP, SSH, FTP, SCP ,Wireshark, Tcpdump, Snoop , Java/JavaScript, HTML, PHP, TCL, TOMCAT/APACHE, MATLAB, NS2, MS OFFICE
Hui Li Photo 52

Hui Li - Wilkes-Barre, PA

Work:
Peking Chef Chinese Restaurant Mar 2010 to 2000
Manager Trainee Wilkes University Development Department - Wilkes-Barre, PA Feb 2007 to Apr 2007
Technician Phonathon American Education Center Fuzhou, Fujian Branch Aug 2006 to Dec 2006
Manager Assistant Fuzhou Trust & Investment Co Feb 2004 to Mar 2004
Computer Technician (Intern)
Education:
Wilkes University Graduate School of Business - Wilkes-Barre, PA Jan 2007 to Dec 2009
MBA Fujian Agriculture and Forest University Sep 2004 to Jul 2006
Bachelor's in Computer Science Fuzhou University Sep 2001 to Jul 2004
Associate in majored

Publications & IP owners

Us Patents

2-Amino Benzoxazinones For The Treatment Of Viral Infections

US Patent:
6380189, Apr 30, 2002
Filed:
Feb 11, 2000
Appl. No.:
09/502038
Inventors:
Norman Abood - Morton Grove IL
Daniel L. Flynn - Mundelein IL
Daniel P. Becker - Glenview IL
Brian M. Bax - St. Lcharles IL
Hui Li - Skokie IL
Roger A. Nosal - Buffalo Grove IL
Lori A. Schretzman - Gurnee IL
Clara I. Villamil - Glenview IL
Assignee:
G.D. Searle Co. - Chicago IL
International Classification:
A61K 31536
US Classification:
5142305, 544 92
Abstract:
A class of compounds for the treatment of viral infections. Compounds of particular interest are defined by Formula I wherein R-R are as defined herein, or a pharmaceutically-acceptable salt thereof.

Aromatic Sulfonyl Alpha-Cycloamino Hydroxamic Acid Compounds

US Patent:
6638952, Oct 28, 2003
Filed:
Dec 23, 1999
Appl. No.:
09/254530
Inventors:
Hui Li - Vernon Hills IL
Daniel P. Becker - Glenview IL
Clara I. Villamil - Glenview IL
Terri L. Boehm - Ballwin MO
Daniel P. Getman - Chesterfield MO
Joseph J. McDonald - Ballwin MO
Gary A. DeCrescenzo - St. Charles MO
Assignee:
Pharmacia Corporation - Skokie IL
International Classification:
A61K 31445
US Classification:
514330, 546221
Abstract:
An aromatic sulfonyl alpha-cycloamino hydroxamic acid compound that inter alia inhibits matrix metalloprotease activity is disclosed as are a treatment process that comprises administering a contemplated aromatic sulfonyl alpha-cycloamino hydroxamic acid compound in a MMP enzyme-inhibiting effective amount to a host having a condition associated with pathological matrix metalloprotease activity.

2-Amino-Benzoxazinones For The Treatment Of Viral Infections

US Patent:
6683077, Jan 27, 2004
Filed:
Jan 4, 2002
Appl. No.:
10/035433
Inventors:
Norman Abood - Morton Grove IL
Daniel L. Flynn - Mundelein IL
Daniel P. Becker - Glenview IL
Brian M. Bax - Irvine CA
Hui Li - Vernon Hills IL
Roger A. Nosal - Buffalo Grove IL
Lori A. Schretzman - Gurnee IL
Clara I. Villamil - Glenview IL
Assignee:
G.D. Searle Co. - St. Louis MO
International Classification:
A61K 31535
US Classification:
5142305, 544 92
Abstract:
A class of compounds for the treatment of viral infections. Compounds of particular interest are defined by Formula I wherein R-R are as defined herein, or a pharmaceutically-acceptable salt thereof.

Aromatic Sulfone Hydroxamic Acid Metalloprotease Inhibitor

US Patent:
6750233, Jun 15, 2004
Filed:
Sep 17, 2001
Appl. No.:
09/954451
Inventors:
Thomas E. Barta - Evanston IL
Daniel P. Becker - Glenview IL
Louis J. Bedell - Mt. Prospect IL
Terri L. Boehm - Ballwin MO
Jeffery N. Carroll - Collinsville IL
Gary A. DeCrescenzo - St. Charles MO
Yvette M. Fobian - Labadie MO
John N. Freskos - Clayton MO
Daniel P. Getman - Chesterfield MO
Joseph J. McDonald - Ballwin MO
Susan L. Hockerman - Chicago IL
Susan C. Howard - Fenton MO
Steve A. Kolodziej - Ballwin MO
Hui Li - Vernon Hills IL
Deborah A. Mischke - Defiance MO
Joseph G. Rico - Ballwin MO
Nathan W. Stehle - Ballwin MO
Michael B. Tollefson - OFallon MO
William F. Vernier - St. Louis MO
Clara I. Villamil - Glenview IL
Assignee:
Pharmacia Corporation - St. Louis MI
International Classification:
A61K 31382
US Classification:
514336, 514252, 514342, 514383, 514432, 544374, 5462801, 5482658, 549 28
Abstract:
A treatment process is disclosed that comprises administering an effective amount of an aromatic sulfone hydroxamic acid that exhibits excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibition at least of MMP-1 to a host having a condition associated with pathological matrix metalloprotease activity. Also disclosed are metalloprotease inhibitor compounds having those selective activities, processes for manufacture of such compounds and pharmaceutical compositions using an inhibitor.

Real Time Business Process Analysis Method And Apparatus

US Patent:
6763353, Jul 13, 2004
Filed:
Oct 31, 2001
Appl. No.:
09/984975
Inventors:
Hui Li - Union City CA
Shelly Xiaolei Qian - Cupertino CA
Assignee:
Vitria Technology, Inc. - Sunnyvale CA
International Classification:
G06F 1730
US Classification:
707 4, 707 2, 707 3, 707 5, 705 1, 705 7, 709310, 718101
Abstract:
A method for monitoring a business process model in which at least one business process object transitions between states. A query having at least one state for the business process object and at least one time-based condition is defined. The query is applied to the business process objects that have changed since a last query application step as a result of execution of the business process model. Events are published when the results of the query are different from previous results of the query. The time based conditions can include conditions compared to actual time and can aggregated values of attributes of plural business process objects and current time.

Intermediates Useful For Making 2,4-Pyrimidinediamine Compounds

US Patent:
7060827, Jun 13, 2006
Filed:
Jun 1, 2004
Appl. No.:
10/858343
Inventors:
Rajinder Singh - Belmont CA, US
Ankush Argade - Foster City CA, US
Donald Payan - Hillsborough CA, US
Susan Molineaux - San Mateo CA, US
Sacha J. Holland - San Francisco CA, US
Jeffrey Clough - Redwood City CA, US
Holger Keim - Menlo Park CA, US
Somasekhar Bhamidipati - Foster City CA, US
Catherine Sylvain - Burlingame CA, US
Hui Li - Millbrae CA, US
Alexander B. Rossi - San Francisco CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
C07D 239/02
US Classification:
544323, 544324, 544320
Abstract:
The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.

Methods Of Treating Or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds

US Patent:
7122542, Oct 17, 2006
Filed:
Jul 30, 2004
Appl. No.:
10/903870
Inventors:
Rajinder Singh - Belmont CA, US
Ankush Argade - Foster City CA, US
Hui Li - Millbrae CA, US
Somasekhar Bhamidipati - Foster City CA, US
David Carroll - San Francisco CA, US
Catherine Sylvain - Burligame CA, US
Jeffrey Clough - Redwood City CA, US
Holger Keim - Menlo Park CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K 19/02
A61K 31/535
C07D 268/36
US Classification:
5142305, 544105
Abstract:
The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with the compounds include rheumatoid arthritis and/or its associated symptoms, systemic lups erythematosis and/or its associated symptoms and multiple sclerosis and/or its associated symptoms.

2,4-Pyrimidinediamine Compounds And Their Uses

US Patent:
7329671, Feb 12, 2008
Filed:
Jun 8, 2005
Appl. No.:
11/148746
Inventors:
Rajinder Singh - Belmont CA, US
Ankush Argade - Foster City CA, US
Donald Payan - Hillsborough CA, US
Susan Molineaux - San Mateo CA, US
Sacha J. Holland - San Francisco CA, US
Jeffrey Clough - Redwood City CA, US
Holger Keim - Menlo Park CA, US
Somasekhar Bhamidipati - Foster City CA, US
Catherine Sylvain - Burlingame CA, US
Hui Li - Millbrae CA, US
Alexander B. Rossi - San Francisco CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A01N 43/54
A01K 31/55
US Classification:
514275, 544323
Abstract:
The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.

Isbn (Books And Publications)

Xian Dai Si Xiang Zheng Zhi Jiao Yu Huan Jing Yan Jiu

Author:
Hui Li
ISBN #:
7218048854

Possible Relatives

Cynthia P Li  Dawn M Li  Daisy Li  Daming Li  Daniel J Li  Deng Li  Dennis C Li  Hui H Lam  Hui Liu  Hui X Su 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.